-
Beyond LDL-C: Why apoB and Lp(a) Matter for Residual Cardiovascular Risk
Recent ACC commentary highlights why apoB and Lp(a) can add important information beyond LDL cholesterol, helping clinicians assess cardiovascular risk more precisely.
-
Turmeric and Liver Health: Understanding the Latest Safety Evidence
International safety alerts and a 2026 USP review put turmeric supplements in context: reassuring clinical-trial findings, rare liver-injury reports, and the importance of formulation-specific evidence and appropriate use.
-
Japan’s FFC GMP Requirements Enter Full Implementation
Japan’s updated manufacturing requirements for specified Foods with Function Claims took full effect in September 2026. The change places renewed emphasis on documented quality management, clear responsibilities and traceability throughout the relevant production supply chain.
-
Nikko Pharma and A. Menarini Mark the PURO Fenōfitto Launch in Kuala Lumpur
Nikko Pharma and partner distributor A. Menarini marked the PURO Fenōfitto launch at “The Metabolic Bloom” in Kuala Lumpur, with a scientific programme developed for healthcare professionals and focused on the research background of botanical ingredients.
-
Japan Grants Conditional, Time-Limited Approval to Two iPSC Therapies
Japan granted conditional, time-limited approval to RiHEART and AMCHEPRY in March 2026. The milestone advances iPSC-based regenerative medicine while underscoring the need for continued evaluation of efficacy and safety after approval in defined clinical settings.
-
2025 European Guidelines Clarify the Role of Prescription EPA
The ESC/EAS lipid guideline update highlights a specific prescription EPA treatment for selected patients, reinforcing why evidence for cardiovascular medicines should not be generalized to fish-oil supplements.
-
Omega-3 and Biological Ageing: What DO-HEALTH Measured
A DO-HEALTH analysis reported modest changes in biological ageing biomarkers with omega-3 over three years. The findings offer a useful research signal, but do not demonstrate longer life or establish benefits for any commercial product.